Back

Low QRS voltages and risk stratification in acute myocarditis : insights from the AMPHIBIA registry

29 August 2026 (11:25 - 11:35)
Organised by: Logo
Congress Presentation Part of: From myocardial injury to remodelling: new biomarkers and therapeutic windows Acute Myocarditis ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Francesco Ravera

Pitie Salpetriere APHP University Hospital, Paris (France)

5 More presentations in this session

Presentation thumbnail
Peak high-sensitivity troponin-T concentration and risk of heart failure in patients with suspected acute coronary syndrome
Doctor P. Ahle Erichsen (Gentofte, DK)
Abstract Slides
Presentation thumbnail
Levosimendan administration and survival in patients receiving mechanical circulatory support: insights from an unselected real-world cohort
Mr E. Ozdemircelik (DE)
Abstract Slides
Presentation thumbnail
Endomyocardial biopsy-based inflammatory phenotypes predict outcomes in virus-negative inflammatory cardiomyopathy
Doctor C. Baumeier (Berlin, DE)
Abstract Slides
Presentation thumbnail
A newborn screening–enabled therapeutic window in late-onset fabry disease: long-term divergent remodeling trajectories with early-stage treatment
Doctor K. Sung (Taipei, TW)
Abstract Slides
Presentation thumbnail
Titin expression in peripheral monocytes as a biomarker of left ventricular dysfunction in acute myocarditis.
Doctor S. Maragkoudakis (Chania, GR)
Abstract Slides

Access the full session

Session thumbnail
From myocardial injury to remodelling: new biomarkers and therapeutic windows
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 11:25 CET
You may be interested in
thumbnail
Congress Presentation
Association between distance to nearest automated external defibrillator and socioeconomic deprivation in Great Britain
28 August 2023
thumbnail
Congress Presentation
Prognostic accuracy of natriuretic peptide levels at hospital admission versus discharge for all-cause mortality in patients presenting with acute dyspnea
31 August 2025
thumbnail
Congress Presentation
Association between personalized evidence-based anticoagulation therapy and outcomes at 1-year follow-up in patients with atrial fibrillation: an analysis from the Atrial Fibrillation Registry
29 June 2021
thumbnail
Congress Presentation
High admission levels of Interleukin-1 receptor antagonist (IL-1RA) in acute MI patients are associated with increased rates of all-cause mortality and cardiac death at 5 years follow-up.
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources